Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04399122 · ClinicalTrials.gov registry record · Phase 4
Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone
A Phase 4 study, sponsored by 59th Medical Wing.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
NCT04399122 is a Phase 4 study that has completed, run by 59th Medical Wing. The registered enrollment target is 200 participants.
The verdict
NCT04399122, a Phase 4 study, has completed, sponsored by 59th Medical Wing.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
Study Summary
Photorefractive keratectomy (PRK) is a refractive error correction procedure that helps eliminate or reduce the dependence on corrective lenses. An important aspect of PRK is post-operative pain management. Post-operative pain can be significant in the first three to five days and is typically controlled utilizing various modalities including narcotic pain medication. Simple observation suggests a difference in the post-operative pain levels of patients utilizing the more potent oxycodone- versus the less potent codeine-containing acetaminophen preparations. There have been no studies performed to explore any differences in perceived pain comparing these two medications when used following PRK. This study is designed to answer this question by means of a pain survey conducted in the first five days post-op. This may help better manage similar patients in the future.
Interventions
- DRUG acetaminophen/codeine vs acetaminophen/oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-03-21 |
| Est. Completion | 2019-10-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04399122
The ClinicalTrials.gov registry entry for NCT04399122 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which acetaminophen/codeine vs acetaminophen/oxycodone is the first listed.
NCT04399122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04399122 about?
NCT04399122 is a clinical study titled "Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone". Photorefractive keratectomy (PRK) is a refractive error correction procedure that helps eliminate or reduce the dependence on corrective lenses. An important aspect of PRK is post-operative pain management. Post-operative pain can be significant in the first three to five days and is typically contr...
What is the current status of trial NCT04399122?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2017-03-21. Estimated completion is 2019-10-28.
What interventions are being tested in trial NCT04399122?
The interventions under investigation include: acetaminophen/codeine vs acetaminophen/oxycodone (DRUG).
Who is sponsoring clinical trial NCT04399122?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.